Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acumen Pharmaceuticals In...

    NASDAQ: ABOS · Real-Time Price · USD
    1.44
    0.04 (2.86%)
    At close: Aug 15, 2025, 2:36 PM

    Acumen Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 35.63M 66.89M 130.1M 122.16M
    Short-Term Investments
    		 135.93M 176.64M 47.5M 72.08M
    Long-Term Investments
    		 59.97M 62.55M 15.84M 31.62M
    Other Long-Term Assets
    		 304K 285K 151K 14K
    Receivables
    		 398K 225K n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 5.33M 1.96M 1.42M 2.83M
    Total Current Assets
    		 178.31M 246.62M 180.33M 198.66M
    Property-Plant & Equipment
    		 339K 503K 270K 36K
    Goodwill & Intangibles
    		 75K 169K n/a n/a
    Total Long-Term Assets
    		 60.69M 63.51M 16.26M 31.67M
    Total Assets
    		 238.99M 310.13M 196.59M 230.33M
    Account Payables
    		 5.65M 1.38M 1.64M 1.09M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 133K 866K 105K n/a
    Other Current Liabilities
    		 21.69M 6.17M 3.95M 2.96M
    Total Current Liabilities
    		 27.61M 12.97M 7.81M 5.15M
    Long-Term Debt
    		 29.42M 29.9M n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 29.57M 30.18M n/a n/a
    Total Liabilities
    		 57.18M 43.15M 7.81M 5.15M
    Total Debt
    		 29.7M 31.05M 105K n/a
    Common Stock
    		 6K 6K 4K 4K
    Retained Earnings
    		 -325.13M -222.8M -170.43M -127.57M
    Comprehensive Income
    		 -48K 312K -751K -231K
    Shareholders Equity
    		 181.82M 266.97M 188.78M 225.18M
    Total Investments
    		 195.9M 239.19M 63.34M 103.69M

    Add to Watchlist